Substance P-Friend or Foe

Overview

Journal J Clin Med

Specialty General Medicine

Date 2022 Jul 9

PMID 35806893

Authors

Prema Robinson

Emma Rodriguez

Miguel Munoz

Affiliations

Soon will be listed here.

Abstract

Substance P (SP), a neuropeptide and pain transmitter has multiple roles and is involved in various processes in the body [...].

Citing Articles

Substance P and Neurokinin-1 receptor are overexpressed in adamantinomatous craniopharyngioma than in the pituitary gland.

Alcaide C, Perez F, Esteban F, Munoz M Pituitary. 2024; 28(1):5.

PMID: 39724307 DOI: 10.1007/s11102-024-01490-0.

References

Bar-Shavit Z, Goldman R, Stabinsky Y, Gottlieb P, Fridkin M, Teichberg V . Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence. Biochem Biophys Res Commun. 1980; 94(4):1445-51. DOI: 10.1016/0006-291x(80)90581-1. View

Bhatia M, Saluja A, Hofbauer B, Frossard J, Lee H, Castagliuolo I . Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis-associated lung injury. Proc Natl Acad Sci U S A. 1998; 95(8):4760-5. PMC: 22564. DOI: 10.1073/pnas.95.8.4760. View

Choi J, Di Nardo A . Skin neurogenic inflammation. Semin Immunopathol. 2018; 40(3):249-259. PMC: 6047518. DOI: 10.1007/s00281-018-0675-z. View

Munoz M, Covenas R . Involvement of substance P and the NK-1 receptor in cancer progression. Peptides. 2013; 48:1-9. DOI: 10.1016/j.peptides.2013.07.024. View

Kroegel C, Giembycz M, Barnes P . Characterization of eosinophil cell activation by peptides. Differential effects of substance P, melittin, and FMET-Leu-Phe. J Immunol. 1990; 145(8):2581-7. View

Marriott I, Bost K . Expression of authentic substance P receptors in murine and human dendritic cells. J Neuroimmunol. 2001; 114(1-2):131-41. DOI: 10.1016/s0165-5728(00)00466-5. View

EULER U, Gaddum J . An unidentified depressor substance in certain tissue extracts. J Physiol. 1931; 72(1):74-87. PMC: 1403098. DOI: 10.1113/jphysiol.1931.sp002763. View

Robinson P, Garza A, Weinstock J, Serpa J, Goodman J, Eckols K . Substance P causes seizures in neurocysticercosis. PLoS Pathog. 2012; 8(2):e1002489. PMC: 3276565. DOI: 10.1371/journal.ppat.1002489. View

Munoz M, Covenas R . The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia. J Clin Med. 2020; 9(6). PMC: 7355887. DOI: 10.3390/jcm9061659. View

10.

Cunin P, Caillon A, Corvaisier M, Garo E, Scotet M, Blanchard S . The tachykinins substance P and hemokinin-1 favor the generation of human memory Th17 cells by inducing IL-1β, IL-23, and TNF-like 1A expression by monocytes. J Immunol. 2011; 186(7):4175-82. DOI: 10.4049/jimmunol.1002535. View

11.

Ho W, Douglas S . Substance P and neurokinin-1 receptor modulation of HIV. J Neuroimmunol. 2004; 157(1-2):48-55. DOI: 10.1016/j.jneuroim.2004.08.022. View

12.

Legi A, Rodriguez E, Eckols T, Mistry C, Robinson P . Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity. Cancers (Basel). 2021; 13(7). PMC: 8038801. DOI: 10.3390/cancers13071732. View

13.

Sun J, Ramnath R, Bhatia M . Neuropeptide substance P upregulates chemokine and chemokine receptor expression in primary mouse neutrophils. Am J Physiol Cell Physiol. 2007; 293(2):C696-704. DOI: 10.1152/ajpcell.00060.2007. View

14.

Ho W, Cnaan A, Li Y, Zhao H, Lee H, Song L . Substance P modulates human immunodeficiency virus replication in human peripheral blood monocyte-derived macrophages. AIDS Res Hum Retroviruses. 1996; 12(3):195-8. DOI: 10.1089/aid.1996.12.195. View

15.

Janelsins B, Mathers A, Tkacheva O, Erdos G, Shufesky W, Morelli A . Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity. Blood. 2008; 113(13):3017-26. PMC: 2662645. DOI: 10.1182/blood-2008-06-163121. View

16.

Serra M, Bazzoni F, Della Bianca V, Greskowiak M, Rossi F . Activation of human neutrophils by substance P. Effect on oxidative metabolism, exocytosis, cytosolic Ca2+ concentration and inositol phosphate formation. J Immunol. 1988; 141(6):2118-24. View

17.

Payan D, Brewster D, Goetzl E . Specific stimulation of human T lymphocytes by substance P. J Immunol. 1983; 131(4):1613-5. View

18.

Chauhan V, Sterka Jr D, Gray D, Bost K, Marriott I . Neurogenic exacerbation of microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi. J Immunol. 2008; 180(12):8241-9. PMC: 2507752. DOI: 10.4049/jimmunol.180.12.8241. View

19.

Bost K . Increased susceptibility of mice to Salmonella infection following in vivo treatment with the substance P antagonist, spantide II. J Immunol. 1996; 157(1):255-64. View

20.

Robinson P, Taffet G, Engineer N, Khumbatta M, Firozgary B, Reynolds C . Substance P receptor antagonism: a potential novel treatment option for viral-myocarditis. Biomed Res Int. 2015; 2015:645153. PMC: 4363507. DOI: 10.1155/2015/645153. View